Adaptive Dosing Strategies for Neonates and Infants in Clinical Trials
Adaptive Dosing Strategies for Neonates and Infants in Clinical Trials Implementing Adaptive Dosing Approaches for Neonates and Infants in Clinical Research Why Adaptive Dosing is Critical in Neonatal and Infant Trials Neonates (≤28 days) and infants (<1 year) present unique challenges in clinical pharmacology due to rapidly changing physiology, immature organ systems, and variability in…
Read More “Adaptive Dosing Strategies for Neonates and Infants in Clinical Trials” »